Edit
On Target Laboratories, Inc.
https://ontargetlabs.com/Last activity: 20.05.2021
Probably Closed
On Target Laboratories discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery so cancerous tissue can be removed more completely. To date, there has been no reliable way for surgeons to assess the location and full extent of cancerous tissue while operating. Our molecular imaging technology, based on the pioneering work of Philip S. Low, PhD, Purdue University's Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, aims to reduce the uncertainty associated with finding and removing cancerous tissue during surgical procedures, helping surgeons to provide a more precise and complete surgical resection. Visit our website to learn more about On Target Laboratories and our targeted intraoperative molecular imaging agents.
Location: United States, Indiana, West Lafayette
Employees: 11-50
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | 3B Future ... | 3bfuturehe... |
Mentions in press and media 6
| Date | Title | Description |
| 20.05.2021 | On Target Laboratories, Inc. Announces Results of Phase 3 Trial for Pafolacianine Sodium Injection for Intraoperative Illumination of Folate Receptor Positive Ovarian Cancer | |
| 24.03.2021 | On Target Laboratories Secures $21 Million for Development and Commercialization of Pafolacianine Sodium Injection | |
| 24.03.2021 | On Target Laboratories Secures $21M in Expanded Series B Funding Round | On Target Laboratories, Inc., a West Lafayette, Ind.-based biotechnology company developing fluorescent markers to target and illuminate cancer during surgery, secured $21m in an expanded Series B funding round. The funding was wholly backe... |
| 03.03.2021 | On Target Laboratories Announces U.S. FDA Acceptance and Priority Review of New Drug Application for pafolacianine sodium injection for Identification of Ovarian Cancer During Surgery | |
| 11.03.2014 | OnTarget Laboratories Receives $15M in Funding | OnTarget Laboratories LLC, a Purdue Research Park of West Lafayette-based developer of an optical imaging technology, received $15m in funding. Backers included the Pension Fund of the Christian Church and Tom Hurvis, founder of Old World I... |
| - | On Target Laboratories | “ON TARGET LABORATORIES discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery so it can be removed completely.” |